11/3
12:15 pm
autl
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Low
Report
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
11/3
12:13 pm
autl
Rating for AUTL
Low
Report
Rating for AUTL
11/3
12:13 pm
autl
Rating for AUTL
Low
Report
Rating for AUTL
10/20
08:08 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Low
Report
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
10/20
05:38 am
autl
Rating for AUTL
Medium
Report
Rating for AUTL
10/20
05:38 am
autl
Rating for AUTL
Medium
Report
Rating for AUTL
9/24
10:31 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its "outperform" rating reaffirmed by analysts at William Blair.
High
Report
Autolus Therapeutics (NASDAQ:AUTL) had its "outperform" rating reaffirmed by analysts at William Blair.
9/24
10:31 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its "outperform" rating reaffirmed by analysts at William Blair.
High
Report
Autolus Therapeutics (NASDAQ:AUTL) had its "outperform" rating reaffirmed by analysts at William Blair.